Table 2.
Beckwith-Wiedemann syndrome genetic type and tissue specific testing
BWS Genetic Type | Methylation (WT) | Methylation (Ipsilateral Kidney sample) | Methylation (blood) | Methylation (skin bx) | SNP | |||||
---|---|---|---|---|---|---|---|---|---|---|
IC1 | IC2 | IC1 | IC2 | IC1 | IC2 | IC1 | IC2 | |||
Patient 1 | IC1 GOM | 90% | 49% | 63% | 50% | 51% | 51% | 57% | 50% | blood: normal WT (1st): normal WT (2nd): normal ipsilateral kidney: normal skin bx: normal |
Patient 2 | pUPD11 | 86% | 3% | 52% | 51% | 49% | 50% | NP | NP | blood: normal ipsilateral kidney: normal |
Patient 3 | IC1 GOM | 88% | 50% | 74% | 49% | 50% | 52% | 52% | 50% | blood: normal WT (1st): no cnLOH 11 ipsilateral kidney: normal skin bx: normal WT (2nd): normal |
Patient 4 | pUPD11 | 66% | 35% | NP | NP | NP | NP | NP | NP | chromosome 11 cnLOH in WT normal chromosome 11 in Ewings sarcoma |
Patient 5 | pUPD11 | NP | NP | NP | NP | NP | NP | NP | NP | WT: cnLOH 11p15.5p13 ipsilateral kidney: normal |
Patient 6 | pUPD11 | 92% | 9% | NP | NP | 50% | 50% | NP | NP | WT: cnLOH in chromosome 11 |
Patient 7 | IC1 GOM | 79% | 51% | NP | NP | NP | NP | NP | NP | WT: normal |
Patient 8 | IC1 GOM | 61% | 50% | NP | NP | NP | NP | NP | NP | NP |
Patient 9 | IC1 KCNQ1 duplication |
88% | 49% | 82% | 50% | NP | NP | NP | NP | not performed |
Patient 10 | pUPD11 | 91% (R) 88% (L) |
2% (R) 4% (L) |
53% | 49% | 50% | 49% | NP | NP | WT: cnLOH 11p15.5p13 (60%
mosaic) ipsilateral kidney margin - normal right side bx - normal |
Patient 11 | pUPD11 | 94.42% | 0.01% | 52% | 50% | 50% | 51% | NP | NP | WT: cnLOH 11p15.5p15.4 (97%
mosaic) left skin bx - normal |
Patient 12 | IC1 GOM | 97% | 49% | 76% | 51% | NP | NP | NP | NP | WT: normal for 11p15
region ipsilateral kidney margin - normal left skin bx - normal |
NP: not performed, GOM: Gain of Methylation, cnLON: copy neutral loss of heterozygosity